Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed News and Future Directions
MS Research Roundup: March 21, 2014
Atacicept Phase 2 Trial Yields Disappointing Results for MS
MS Patient, Ph.D.: Axes of Access Don’t Intersect for the Disabled Patient
MS Patient, Ph.D.: Exercise in MS: Good or Bad?
Damage to Strategic Brain Regions May Explain Fatigue in MS
High Noon at the Th17 Corral
Eyeing Neurodegeneration
First-Attack Multiple Sclerosis Targets Gray Matter
Gavin Giovannoni's "Tube Map" for MS
Lower Risk of MS in People With HIV
Exploiting the EBV-MS Link to Quell Secondary Progressive Disease
Fuel Injection
Stem Cells Stop the Train of MS Damage in Mice
MS Research Roundup: July 9, 2014
MS Research Roundup: March 31, 2014
Abnormal Venous Outflow Dynamics May Not Be Implicated in MS
MS Genetics: The Outer Limits
Peripheral B Cell Activation May Drive CNS Autoimmunity in MS
FDA Approves Alemtuzumab for MS
Conducting Neural Dissonance
Episode 82 with Dr. Adam Kaplin on depression & MS
Low Vitamin D May Not Be Linked to Epstein-Barr Virus Status
Dimethyl Fumarate Shows Efficacy in Phase III Clinical Studies
MS Patient, Ph.D.: Home From the Hospital
Deep and Cortical Gray Matter Degeneration in MS Driven by Different Factors
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
